Abstract:Objective:To explore the predictive value of diffusing capacity for chronic obstructive pulmonary disease (COPD) complicated with lung cancer.Methods:This was a case-control study.The clinical data of 421 patients with COPD complicated with lung cancer who were admitted to the First Hospital of Lanzhou University from March 2008 to October 2021 were collected by non-randomized control method, and the clinical data were compared with those of the patients with COPD (708 cases) and lung cancer (438 cases).The diffusing capacity of different clinical stages of lung cancer was compared, and the correlation between diffusing capacity and clinical stage was analyzed.Multivariate logistic regression was used to analyze the relationship between diffusing capacity and lung cancer in COPD patients.The predictive value of diffusing capacity for COPD complicating lung cancer was explored by receiver operating characteristic (ROC) curve analysis.Results:The proportion of male, smoking rate, and smoking index in COPD complicating lung cancer group were higher than those in the COPD and lung cancer groups (all P<0.05).The age of COPD complicating lung cancer group was older than that of the lung cancer group, and body mass index (BMI) was lower than that of the COPD group (all P<0.05).Compared with the lung cancer group, in the COPD complicating lung cancer group, the proportion of squamous cancer was higher while the frequency of adenocarcinoma was lower (all P<0.05).There were no significant differences in the maximum tumor diameter, the proportion of large airway invasion, and pulmonary artery compression between the COPD complicating lung cancer group and the lung cancer group.There were no differences in lung ventilation function, small airway function, residual volume, residual/total ratio, and GOLD grade between COPD complicating lung cancer group and COPD group.Compared with lung cancer group, in COPD complicating lung cancer group, lung ventilation function and small airway function were significantly decreased while residual volume and residual/total ratio were increased (all P<0.05).The diffusing capacity of COPD complicating lung cancer group was lower than that of COPD and lung cancer groups, and the proportion of patients with decreased diffusion function in different degrees in COPD complicating lung cancer group was significantly higher than that in COPD group and lung cancer group (all P<0.05).The higher the TNM stage of the NSCLC patients in the COPD complicating lung cancer group and the lung cancer group, the lower the diffusing capacity.Spearman correlation analysis showed that the diffusing capacity was negatively correlated with the TNM stage of the NSCLC patients in the COPD complicating lung cancer group and lung cancer group.Multivariate logistic regression analysis showed that the risk of lung cancer in COPD group with severely decreased diffusing capacity was 2.771 times higher than that in normal diffusing capacity group after adjusting for gender, age, BMI, smoking history, and smoking index (95% CI: 1.211-6.338, P=0.016).ROC curve suggested that the optimal thresholds of diffusing capacity of carbon monoxide (D LCO), D LCO percent predicted value (D LCO%pred), diffusing capacity of carbon monoxide per liter of alveolar volume(D LCO/VA), and D LCO/VA percent predicted value (D LCO/VA%pred) for predicting COPD complicating lung cancer were respectively 7.12 mmol·min -1·kPa -1, 87.95%, 1.24 mmol·min -1·kPa -1·L -1, 101.25%; the sensitivity and specificity were 65.6% and 46.8%, 62.5% and 60.2%, 49.2% and 73.6%, 64.8% and 58.8%, respectively; the areas under the curve were 0.582, 0.653, 0.651 and 0.647, respectively.D LCO%pred had the best prediction effect.The AUCs of FEV 1%pred combined with D LCO, D LCO%pred, D LCO/VA, and D LCO/VA%pred were 0.582, 0.656, 0.651, 0.647, respectively; and the sensitivity and specificity were 35.4% and 76.7%, 76.2% and 47.0%, 52.0% and 71.6%, 64.4% and 59.5%, respectively. Conclusions:Diffusing capacity is associated with COPD complicating lung cancer, and has certain predictive value for COPD complicating lung cancer.

The role of lung diffusing capacity for carbon monoxide in Pulmonary Langerhans Cell Histiocytosis

Clinical Research of Pulmonary Langerhans Cell Histiocytosis in Children.

Pulmonary Langerhans cell histiocytosis: analysis of 14 patients and literature review.

Clinical analysis for 15 patients with pulmonary Langerhans cell histiocytosis and literature review

Diagnosis of Interstitial Lung Disease in Patients with Connective Tissue Disease by the Diffusing Capacity of Carbon Monoxide.

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

Pulmonary Langerhans Cell Histiocytosis: Case Series and Literature Review.

Diffusing capacity of the lung for carbon monoxide: association with long-term outcomes after lung transplantation in a 20-year longitudinal study

CT Findings of Pulmonary Langerhans Cell Histiocytosis

[Profile of patients evaluated with the Carbon Monoxide Diffusion Capacity Test: A Chilean experience]

Analysis on Pulmonary Langerhans Cell Histiocytosis

Evaluation of the interstitial histological lesions in pulmonary langerhans cell histiocytosis

Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights

Immune Microenvironment Associated with the Severity of Langerhans Cell Histiocytosis in Children.

Pulmonary involvement in children with Langerhans cell histiocytosis

Clinical Study on Interstitial Lung Disease in Children of China

Predictive value of diffusing capacity in patients with chronic obstructive pulmonary disease complicating lung cancer

Isolated abnormal diffusing capacity for carbon monoxide (iso↓DLco) is associated with increased respiratory symptom burden in people with HIV infection

Measurement of diffusion lung capacity (DLCO) in silicosis patients: Correlation with radiographic abnormalities on high-resolution CT scan chest

Interstitial Lung Disease in Children: High-Resolution CT Findings in 14 Patients

Clinica analysis of three cases of pulmonary langerhans cell histocytosis